mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal - Volume 23, Number 8—August 2017 - Emerging Infectious Diseases journal - CDC

Overview of attention for article published in Emerging Infectious Diseases, August 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 58 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,110 followers.

mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal. https://t.co/j9OhyAelEt

Reply Repost Favourite

https://t.co/b86xk2hClT It's amazing how quickly bacteria can adapt to be #AMR.

Reply Repost Favourite

mcr-1 and blaKPC-3 in E. coli ST744 after Meropenem and Colistin Therapy, Portugal #EIDjournal #AMR https://t.co/FCnpaq5kap

Reply Repost Favourite